午评：三大指数半日收跌 影视院线板块爆发

Market Overview - The market experienced narrow fluctuations in early trading, with the three major indices turning negative again [1] - By the close, the Shanghai Composite Index was at 4122.34 points, down 0.02%; the Shenzhen Component Index was at 14206.26 points, down 0.02%; and the ChiNext Index was at 3328.02 points, down 0.14% [2] Sector Performance - The film and television sector continued to rise, with stocks like Jiecheng Co. and Light Media hitting the daily limit up of 20%, alongside several others [1][5] - The AI application sector remained strong, with Rongxin Culture and Zhangyue Technology achieving consecutive gains [1] - The innovative drug sector saw a rebound, with Haixiang Pharmaceutical, Wanbangde, and Jihua Group all hitting the daily limit up [1][4] - Conversely, the non-ferrous metals sector declined, particularly in precious metals, with Xiaocheng Technology experiencing significant losses [1] - The liquor sector showed weak performance, led by Huangtai Liquor, while the battery sector also fell, with Jinyinhai experiencing notable declines [1] Key Highlights Innovative Drugs - The innovative drug sector is projected to reach a record transaction scale of $135.7 billion for License-out deals in China by 2025, with significant collaborations occurring in early 2026 [4] - Notable deals include the $18.5 billion partnership between Shiyao and AstraZeneca, and a $5.6 billion deal between Rongchang and AbbVie, highlighting the global value of domestic innovative drug pipelines [4] Film and Television - As of February 9, the pre-sale box office for new films during the 2026 Spring Festival has exceeded 70 million yuan [5] - CICC's report estimates that the total box office for this year's Spring Festival could range between 6.5 billion and 8.5 billion yuan, with the performance of leading films being crucial for the final box office outcome [5]